332 results
Page 5 of 17
8-K
EX-1.1
uv6 3cfmj3
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
424B5
uyswi3njt
17 Feb 21
Prospectus supplement for primary offering
12:00am
424B5
7fc5e
11 Feb 21
Prospectus supplement for primary offering
5:28pm
8-K
EX-10.1
82r3gdj 2so
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm
424B2
2g1ihvxu4mbajw6cxi5f
2 Oct 20
Prospectus for primary offering
4:16pm
8-K
EX-10.1
r0wfmm72mk6m0ys0eirf
25 Sep 20
Diffusion Pharmaceuticals Strengthens Management Team with Appointmentof William Elder as General Counsel and Corporate Secretary
4:57pm
8-K
EX-10.2
eit9np1lv5nk46c5b hc
9 Sep 20
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
9:30am
8-K
EX-99.1
wvf8pvcwpvugqmmae78u
10 Aug 20
Diffusion Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
5:00pm
8-K
EX-99.1
raamzvireqlqfu9cw0v2
29 Jul 20
Diffusion Pharmaceuticals Receives FDA Guidance for International Phase 1b/2b COVID-19 Clinical Program with TSC
8:14am
8-K
EX-99.1
ig9kgukm sl
7 Jul 20
Phase 1b dosing expected to begin this month
4:38pm
8-K
EX-99.1
2ln6rh
12 Jun 20
Dosing expected to begin in Q2 2020 with first data in Q3 2020
12:18pm